JamesThomasBoydMD
Neurology • Burlington, VTMovement Disorder, Neurophysiology
Professor, Neurological Sciences, University of Vermont College of Medicine
Dr. Boyd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 South Prospect Street
Arnold, Level 2
Burlington, VT 05401Phone+1 802-847-4589
Education & Training
University of Vermont Medical CenterFellowship, Clinical Neurophysiology, 2004 - 2005- University of Vermont Medical CenterResidency, Neurology, 2001 - 2004
- University of Vermont Medical CenterInternship, Internal Medicine, 2000 - 2001
Memorial University of Newfoundland FOMClass of 2000
Certifications & Licensure
VT State Medical License 2004 - 2026
NY State Medical License 2022 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Nicotine Treatment of Impulsivity in Parkinson's Disease Start of enrollment: 2010 Oct 01
- Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease Start of enrollment: 2012 Oct 01
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsTransdermal Nicotine Treatment and Progression of Early Parkinson's Disease.Wolfgang H Oertel, Hans-Helge Müller, Marcus M Unger, Carmen Schade-Brittinger, Kerstin Balthasar
NEJM Evidence. 2023-09-01 - 1 citationsPallidal stimulation-induced psychosis and suicidality in Parkinson's disease.Sebastian Hanna, Vala Palmadottir, Paul L Penar, James T Boyd
Clinical Parkinsonism & Related Disorders. 2023-01-01 - 124 citationsTrial of Prasinezumab in Early-Stage Parkinson's Disease.Gennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, Maddalena Marchesi, Tanya Simuni
The New England Journal of Medicine. 2022-08-04
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
